Stereotaxis, which designs, manufactures and markets an advanced cardiology instrument control, has appointed Samuel Duggan as chief financial officer (CFO). Duggan will report to president and chief executive officer (CEO) Michael Kaminski.
Duggan has 25 years of financial leadership experience. He was vice president and treasurer of RehabCare Group from 2009 until its 2011 acquisition by Kindred Healthcare. During this time, Duggan had management responsibility for treasury, investor relations, financial analysis, budgeting and lease financing.
From 2005 to 2008, Duggan held various finance positions of increasing responsibility at Kellwood Company, one of the largest apparel makers in the US, concluding with his role as corporate vice president, investor relations and treasurer. Immediately prior to Kellwood, he was with MEMC Electronic Materials, where he held various positions in accounting, business development, purchasing, facilities planning and investor relations, starting in 1996. Duggan was with KPMG from 1986 until 1996 culminating with his role as an audit senior manager.
Duggan replaces Dan Johnston, who left the company in August 2011.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.